From October 1, 2023 to December 31, 2023, the company has repurchased 957,000 shares, representing 0.21% for $26.15 million. With this, the company has completed the repurchase of 9,846,000 shares, representing 2.19% for $304.77 million under the buyback announced on March 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.27 USD | -2.19% | -2.92% | -2.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.92% | 12.3B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.